Suzanne C. O`Neill, Ph.D. Department of Oncology Georgetown

advertisement
Suzanne C. O'Neill, Ph.D.
Department of Oncology
Georgetown University Medical Center
Harris Building, Suite 4100
3300 Whitehaven Street, NW
Washington, DC 20007
T: 202-687-0869; F: 202-687-0305
[email protected]
1. PERSONAL INFORMATION
A. Education:
Undergraduate:
University of Notre Dame, Notre Dame, IN, 1991-1995, B.A., Psychology
Graduate Education:
University of Illinois at Urbana-Champaign, Urbana, IL, 1995-1997, M.A.,
Counseling Psychology
Graduate Education:
University of Delaware, Newark, DE, 1999-2004, Ph.D., Clinical Psychology,
Graduate Advisor: Lawrence H. Cohen, Ph.D.
Internship:
Medical University of South Carolina, Department of Psychiatry and Behavioral
Sciences, Charleston, SC, 2003-2004, Director: Dean Kilpatrick, Ph.D.
Fellowship:
University of North Carolina, Lineberger Comprehensive Cancer Center, Chapel
Hill, 2004-2006, Mentor: Barbara K. Rimer, Dr. P.H.
Fellowship:
National Human Genome Research Institute, NIH, Bethesda, MD, 2006-2008,
Mentor: Colleen M. McBride, Ph.D.
B. Professional Experience:

Assistant Professor of Oncology, Tenure-Track Faculty, Lombardi Comprehensive Cancer Center
(LCCC), Georgetown University Medical Center, Washington, DC, 8/08-present

NIH Women’s Health Postdoctoral Fellowship, National Human Genome Research Institute,
NIH, Bethesda, MD, 8/06-7/08

Cancer Control Education Program (NCI R25) Postdoctoral Fellow, University of North
Carolina, Lineberger Comprehensive Cancer Center, Chapel Hill, NC, 8/04-7/06

Clinical Psychology Intern, Department of Psychiatry and Behavioral Sciences, Medical
University of South Carolina, Charleston, SC, 8/03-7/04
C. Licensure:
State: Maryland
License No: 04620
Initial Date: 2008
Renewal/Expiration Date: 3/31/2016
State: District of Columbia
License No: PSY1000958
Initial Date: 2014
Renewal/Expiration Date: 12/31/2015
D. Certification:
N/A
E. Languages Spoken:
N/A
2. RESEARCH AND SCHOLARLY ACTIVITIES
A. Publications:
i. Original Papers in Refereed Journals
1. O’Neill SC, Isaacs C, Chao C, Tsai HT, Liu C, Ekezue BF, Selvam N, Kessler LG, Schwartz
MD, Lobo T, Potosky AL. Adoption of Gene Expression Profiling for Breast Cancer in US
Oncology Practice for Women Under Age 65. Journal of the National Comprehensive Cancer
Network. In Press. PMID: In process PMCID: In process
2. Potosky AL, O’Neill SC, Isaacs C, Chao C, Tsai HT, Liu C, Ekezue BF, Selvam N, Kessler LG,
Schwartz MD. Adoption of Gene Expression Profiling for Breast Cancer in US Oncology
Practice for Women Under Age 65. Cancer. 2015 Aug 20. PMID: 26291519 PMCID: In process
3. Tercyak KP, Silber E, Johnson AC, Fleischmann A, Murphy SE, Shoretz R, Mays DM, O’Neill
SC, Sharkey CM. Addressing the information and support needs of jewish women at increased
risk for or diagnosed with breast cancer: The Sharsheret experience. Healthcare. In Press. PMID:
In process PMCID: In process
4. *O’Neill SC, Tercyak K, Baytop C, Hensley Alford S, McBride CM. A new approach to
assessing affect and the emotional implications of personal genomic testing for common disease
risk. Public Health Genomics. 2015; 18: 104-112. PMID: 25612474 PMCID: PMC4348333
5. *O’Neill SC, Mays DM, Patenaude AF, Garber JE, DeMarco, TA, Peshkin BN, Schneider KA,
Tercyak KP. Women’s concerns about heritable breast cancer risk and its implications for their
children. Journal of Community Genetics. 2015;6: 55-62. PMID: 25099078 PMCID:
PMC4286561
6. Sheppard VB, O’Neill SC, Dilawari A, Horton S, Hirpa F, Isaacs C. Patterns of 21-gene assay
testing and chemotherapy use in Black and White breast cancer patients. Clinical Breast Cancer.
2015; 15: e83-92. PMID: 2555816 PMCID: In process
7. *O’Neill SC, Leventhal KG, Scarles M, Evans C, Makariou E, Pien E, Willey S. Mammographic
breast density as a risk factor for breast cancer: Awareness in a recently-screened clinical sample.
Women’s Health Issues. 2014; 24: e321-326. PMID: 24725756 PMCID: PMC4011971
8. Sanderson SC, McBride CM, Shepperd J, O’Neill SC, Docherty S, Lipkus IM. Young smokers’
interpretations of the estimated lung cancer risk associated with a common genetic variant of low
penetrance. Public Health Genomics. 2014; 17: 68-75. PMID: 24556984 PMCID: PMC4446710
9. Harris JN, Liljestrand P, Alexander G, Goddard KAB, Kauffman T, Kolevska T, McCarty C,
O’Neill SC, Pawloski P, Rahm A, Williams A, Somkin C. Oncologists’ attitudes toward KRAS
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
20.
21.
testing: A Multi-site study. Cancer Medicine. 2013; 2: 881-888. PMID: 24403261 PMCID:
PMC3892392
Shepperd J, Novell CA, O’Neill SC, Docherty S, Sanderson SC, McBride CM, Lipkus IM.
Contemplating genetic feedback regarding lung cancer susceptibility. Annals of Behavioral
Medicine. 2013; 47: 395-403. PMID: 24222509 PMCID: PMC400864
*O’Neill SC, DeFrank JT, Vegella P, Richman AR, Henry LR, Carey LA, Brewer NT. Health
behaviors among women receiving genomic testing for breast cancer recurrence risk. PLoS One.
2013; 8: e53607. PMID: 23326466 PMCID: PMC3543271
Spellman E, Sulayman N, Eggly S, Isaacs C, Peshkin B N, Schwartz MD, *O’Neill SC. Utility of
genomic recurrence risk estimates in the treatment of patients with early stage breast cancer:
Physician perspectives. Psycho-Oncology. 2013; 22: 2110-2116. PMID: 23447452 PMCID:
PMC3757108
Shepperd J, Lipkus IM, Sanderson SC, McBride CM, O’Neill SC, Docherty S. Conveying
genetic susceptibility to lung cancer to college smokers: Tests of different communication
formats. Journal of Health Communication. 2013; 18: 124-137. PMID: 22888806 PMCID:
PMC3543503
*O’Neill SC, Lipkus, IM, Sanderson SC, Shepperd J, Docherty S, McBride, CM. Reliability and
predictive validity of a measure of motivations for genetic testing for common disease risk.
Tobacco Control. 2013; 22: 406-411. PMID: 22744911 PMCID: PMC3586780
King L, *O’Neill SC, Spellman E, Peshkin BN, Valdimarsdottir H, Willey S, Leventhal KG,
DeMarco T D, Nusbaum R, Schwartz MD. Intentions for bilateral mastectomy among newly
diagnosed breast cancer patients. Annals of Surgical Oncology. 2012; 107: 772-776. PMID:
23280632 PMCID: PMC3687585
Sulayman N, Spellman E, Graves KD, Peshkin BN, Isaacs C, Schwartz MD, *O’Neill SC.
Psychosocial and quality of life outcomes in women receiving the 21-gene Recurrence Score
assay: the impact of decision style in women with intermediate RS. Journal of Cancer
Epidemiology, Special Issue on Translational Genomics. 2012, 728290. PMID: 22899924
PMCID: PMC3413972
*O’Neill SC, Lipkus IM, Gierisch JM, Rimer BK, Bowling JM. It’s the amount of thought that
counts: When ambivalence predicts mammography screening. Women’s Health Issues. 2012; 22:
e189-194. PMID: 22055988 PMCID: PMC3276699
Docherty S, McBride CM, Sanderson SC, O’Neill SC, Shepperd J, Lipkus IM. Young smokers’
views of genetic susceptibility testing for lung cancer risk: Minding uinintended consequences.
Community Genetics. 2011; 2: 165-172. PMID: 21860660 PMCID: PMC3158470
*O’Neill SC, McBride CM, Alford SH, Kaphingst KA. Preferences for genetic and behavioral
health information: The impact of risk factors and disease attribution. Annals of Behavioral
Medicine. 2010; 40: 127-137. PMID: 20532842 PMCID: PMC3498951
*O’Neill SC, Valdimarsdottir H, DeMarco T, Peshkin B N, Graves KD, Brown K, Hurley KE,
Isaacs C, Hecker S, Schwartz MD. BRCA1/2 test results and change in attitude towards risk
management strategies. Breast Cancer Research and Treatment. 2010; 124: 755-764. PMID:
20383578 PMCID: PMC3039480
*O’Neill SC, Thompson CL, Worthington J, Kapp J, Graves KD, Madlensky L. Job satisfaction
in cancer prevention and control: A survey of the American Society of Preventive Oncology.
Cancer, Epidemiology, Biomarkers and Prevention. 2010; 19: 2110-2112. PMID: 20696666
PMCID: PMC3031912
22. Sanderson S, O’Neill SC, Bastian L, Bepler G, McBride, CM. What can interest tell us about
uptake of genetic testing? Intention and behavior amongst smokers related to patients with lung
cancer. Public Health Genomics. 2010; 13: 116-124. PMID: 19556750 PMCID: PMC3696369
23. *O’Neill SC, Peshkin BN, Luta G, Abraham A, Walker L, Tercyak KP. Primary care providers’
willingness to recommend BRCA1/2 testing to adolescents. Familial Cancer. 2010; 9: 43-50.
PMID: 19390990 PMCID: PMC3514889
24. Gierisch JM, O’Neill SC, Bowling JM, Lipkus IM, Rimer BK, Strigo TS, Skinner CS. Factors
associated with annual-interval mammography for women in their 40s. Cancer Epidemiology.
2009; 33: 72-78. PMID: 19481879 PMCID: PMC2727566
25. Sanderson S, O’Neill SC, White DB, Bepler G, Bastian L, Lipkus IM, McBride CM. Responses
to online GSTM1 genetic test results amongst smokers related to patients with lung cancer: A
pilot study. Cancer, Epidemiology, Biomarkers and Prevention. 2009; 18: 1953-1961. PMID:
19567511 PMCID: PMC3417294
26. Rini C, O’Neill SC, Valdimarsdottir H, Goldsmith R, Demarco T, Peshkin BN, Schwartz MD.
Predictors of decision conflict trajectories among breast cancer survivors who receive
uninformative BRCA1/2 results. Health Psychology. 2009; 28: 569-578. PMID: 19751083
PMCID: PMC3510002
27. Schwartz MD, Valdimarsdottir H, DeMarco T, Peshkin BN, Lawrence W, Rispoli J, Brown K,
Isaacs C, O’Neill SC, Shelby R, Grumet SC, Rogers S, Bremer H, Leaman S, Cuneo K,
Komaridis K. Randomized trial of a decision aid for BRCA1/BRCA2 mutation carriers: Impact on
measures of decision making and satisfaction. Health Psychology. 2009; 28: 11-19. PMID:
19210013 PMCID: PMC3580845
28. *O’Neill SC, Rini C, Goldsmith R, Valdimarsdottir H, Cohen LH, Schwartz MD. Distress among
women receiving uninformative BRCA1/2 results: 12-month outcomes. Psychooncology. 2009;
18: 1088-1096. PMID: 19214961 PMCID: PMC3503506
29. Brewer NT, Edwards A, O’Neill SC, Tzeng JP, Carey L A, Rimer BK. When genomic and
standard test results diverge: implications for breast cancer patients' preference for chemotherapy.
Breast Cancer Research and Treatment. 2009; 117: 25-9. PMID: 18785002
30. *O’Neill SC, Luta G, Peshkin BN, Abraham A, Walker L, Tercyak K. Adolescent medical
providers’ willingness to offer genetic susceptibility testing: Influence of disease, lifestyle and
other factors. Journal of Pediatric Psychology. 2008; 34: 617-626. PMID: 18687733 PMCID:
PMC2699247
31. *O’Neill SC, Bowling JM, Brewer NT, Lipkus IM, Strigo TS, Skinner CS, Rimer BK. Women’s
intentions to maintain adherence to mammography. Journal of Women’s Health. 2008; 17: 11331141. PMID: 18657041 PMCID: PMC2575244
32. *O’Neill SC, Kaufman E, DeMarco T, Peshkin BN, McKenna K, Shelby R, Valdimarsdottir H,
Rispoli J, Schwartz MD. Changes in diet and physical activity following BRCA1/2 testing.
Journal of Psychosocial Oncology. 2008; 26: 63-80. PMID: 19042265
33. Morrill EF, Brewer NT, O'Neill SC, Rimer BK, Lillie S E, Dees EC, Carey LA. The interaction
of post-traumatic growth and post-traumatic stress symptoms in predicting depressive symptoms
and quality of life. Psycho-oncology. 2008; 17: 948-953. PMID: 18213677
34. *O’Neill SC, White DB, Sanderson SC, Lipkus IM, Bepler G, Bastian L, McBride CM. The
feasibility of online genetic testing for lung cancer susceptibility: Uptake of a web-based protocol
and decision outcomes. Genetics in Medicine. 2008; 10: 121-130. PMID: 18281920
35. *O’Neill SC, Brewer NT, Lillie SE, Morrill EF, Dees EC, Carey LA, Rimer BK. Women’s
interest in gene expression analysis for breast cancer recurrence risk. Journal of Clinical
Oncology. 2007; 25: 4628-4634. PMID: 17925559
36. Lillie SE, Brewer NT, O’Neill SC, Morrill EF, Dees EC, Carey LA, Rimer BK. Retention and
use of breast cancer recurrence risk information: The role of health literacy. Cancer,
Epidemiology, Biomarkers and Prevention. 2007; 16: 1-7. PMID: 17267389
37. *O’Neill SC, DeMarco T, Peshkin BN, Rogers S, Rispoli J, Brown K, Valdimarsdottir H,
Schwartz MD. Tolerance for uncertainty, perceived risk and distress among women receiving
uninformative BRCA1/BRCA2 results. American Journal of Medical Genetics. 2006; 142C: 251259. PMID: 17024668
38. Carter CL, Zapka JG, O’Neill SC, DesHarnais S, Hennessy W, Kurent J, Carter, R. Clinical
perspectives in end-of-life care: Factors of race, specialty and location. Palliative and Supportive
Care. 2006; 4: 257-271. PMID: 17066967
39. Cohen LH, Gunthert KC, Butler AC, O’Neill SC, Tolpin, LH. Daily affective reactivity as a
prospective predictor of depressive symptoms. Journal of Personality. 2005; 73: 1687-1714.
PMID: 16274450
40. *O’Neill SC, Cohen LH, Tolpin LH, Gunthert KC. Affective reactivity to daily interpersonal
stressors as a prospective predictor of depressive symptoms. Journal of Social and Clinical
Psychology. 2004; 23: 172-194.
41. Tolpin LH, Gunthert KC, Cohen LH, O’Neill SC. Borderline personality features and instability
of daily negative affect and self-esteem. Journal of Personality. 2004; 72: 111-138. PMID:
14686886
42. Kaufman EM, Peshkin BN, Lawrence WF, Shelby R, Isaacs C, Brown K, Rispoli J, O’Neill S,
Hurley K, De Marco T, Brogan B, Grumet S, Jandorf L, McKenna K, Valdimarsdottir H,
Schwartz MD. An interactive decision aid for risk management decision-making in female
BRCA1/2 carriers. Journal of Genetic Counseling. 2003; 12: 109-129.
43. Tidey JW, O’Neill SC, Higgins ST. Contingent monetary reinforcement of smoking reductions
with and without transdermal nicotine in outpatients with schizophrenia. Experimental and
Clinical Psychopharmacology. 2002; 10: 241-247. PMID: 12233984
44. Tidey JW, O’Neill SC, Higgins ST. d-amphetamine increases choice of cigarette smoking over
monetary reinforcement. Journal of Psychopharmacology. 2000; 153: 85-92. PMID: 11255931
45. Tidey JW, O’Neill SC, Higgins ST. Effects of abstinence on cigarette smoking among outpatients
with schizophrenia. Experimental and Clinical Psychopharmacology. 1999; 7: 347-353. PMID:
10609969
ii. Reviews or Editorials in Refereed Journals
1. Graves KD, Hay J, *O’Neill SC.+ The promise of using personalized genomic information to
promote behavior change: Is the debate over or just beginning? Personalized Medicine. 2014; 11:
173-185. (Invited Commentary). +equal contributions by all authors.
2. Tercyak KP, O’Neill SC, Roter DL, McBride CM. Bridging the Communication Divide: A Role
for Health Psychology in the Genomic Era. Professional Psychology: Research and Practice.
2012; 43: 568-575. PMID: 23503693 PMCID: PMC3595505
iii. Books or Chapters in Books (Refereed)
1. O’Neill SC. Public health genomics. In K. P. Tercyak (Ed.) Handbook of Genomics and the
Family: Psychosocial Context for Children and Adolescents. Springer: New York, 2010.
vi. Other Publications
1. Studts JL, Kivimiemi MT, O’Neill SC. Health Decision Making SIG Update. Society of
Behavioral Medicine Outlook, Fall 2010.
2. O’Neill SC, Hay J, Politi MC. Health Decision Making SIG Blog. www.sbm.org, June, 2012.
3. O’Neill SC, Bryan A, Koehly L, Wideroff L, McBride, CM. Cancer: The Front Line of Genomic
Translation. Journal of Cancer Epidemiology. 2012, 372597. PMID: 23209467 PMCID:
PMC3503331
4. O’Neill SC, Hay J, Kivimiemi MT. Health Decision Making SIG Update. Society of Behavioral
Medicine Outlook, Fall 2012.
v. Abstracts for Conference papers and posters
1. Tercyak KP, O’Neill SC, DeMarco T, Lewis FM. (2015, October). Understanding Psychological
outcomes among couples affected by genetic breast cancer risk: Counseling Implications.
Proceedings of the National Society of Genetic Counselors Annual Meeting, Pittsburgh, PA.
2. Potosky AL, O’Neill SC, Isaacs C, Chao C, Tsai HT, Liu C, Ekezue BF, Selvam N, Kessler LG,
Schwartz MD. (2015, August). Effects of gene expression profiling on adjuvant chemotherapy
use in women under age 65 with breast cancer in community practice. Proceedings of the
International Society of Pharmacoepidemiology Annual Meeting, Boston, MA.
3. Evans C, Eggly S, Isaacs C, Schwartz MD, Vadaparampil S, O’Neill SC. (2015, August). Risk of
Recurrence and Quality of Provider Communication Predict Treatment-Related Decisional
Conflict among Women with Breast Cancer. Proceedings of the Annual Meeting of the
International Psychosocial Oncology Society, Washington, DC.
4. Evans C, Nusbaum R, Isaacs C, Tercyak KP, O’Neill SC. (2015, April). Assessing patient
education and counseling needs of young women at high risk for breast cancer. Proceedings of
the Annual Meeting of the Society of Behavioral Medicine, San Antonio, TX.
5. O’Neill SC, Schwartz MD, Peshkin BN, Eggly S, Brewer NT, Isaacs C. (2014, April). Genomic
recurrence risk estimates and receipt of chemotherapy for breast cancer. Proceedings of the
Annual Meeting of the Society of Behavioral Medicine, Philadelphia, PA.
6. Evans C, Willey S, Makariou E, Pien E, Leventhal KG, Scarles M O’Neill SC. (2014, April).
Integrating breast density into risk counseling: pilot intervention outcomes. Proceedings of the
American Society of Preventive Oncology Annual Meeting, Arlington, VA.
7. O’Neill SC, Sulayman N, Spellman E, Leventhal KG, Scarles M. (2013, April). Women’s
Awareness of Mammographic Breast Density. Proceedings of the Annual Meeting of the Society
of Behavioral Medicine, San Francisco, CA.
8. O’Neill SC, Sulayman N, Spellman E, Leventhal KG, Scarles M. (2013, April). Mammographic
Breast Density as a Breast Cancer Risk Factor: implications for Intervention. Proceedings of the
Annual Meeting of the Society of Behavioral Medicine, San Francisco, CA.
9. O’Neill SC, Sulayman N, Spellman E, Graves KD, Peshkin BN, Schwartz MD. (June, 2012).
Associations between genomic breast cancer recurrence risk estimates and treatment and
screening utilization. Proceedings of the Annual Meeting of AcademyHealth, Orlando, FL.
10. Liljestrand P, Harris J, Alexander G, Goddard K, Kauffman T, Kolevska T, McCarty C, O’Neill
SC, Pawloski P, Rahm A, Williams A, Somkin, C. (May, 2012). Patient views of KRAS testing
for treatment of mCRC. Proceedings of the HMO Research Network Meeting, Seattle
Washington.
11. O’Neill SC, DeFrank JT, Vegella P, Richman AR, Henry LR, Carey LA, Brewer NT. (April,
2012). Health behaviors among women receiving genomic testing for breast cancer recurrence
risk. Proceedings Society of Behavioral Medicine, New Orleans, LA.
12. Spellman E, Sulayman N, DeMarco TA, Sharff ME, Tercyak KP, Friedman S, O’Neill SC.
(March, 2012). Listening to the Internet: Young previvors needs for decision and psychosocial
support. Proceedings of the Annual Meeting of the American Society of Preventive Oncology,
Washington, DC.
13. Somkin C, Liljestrand P, Harris J, Kolevska T, Alexander G, Kauffman T, McCarty C, O’Neill
SC, Pawloski P, Rahm A, Williams A, Goddard, K. (March, 2011). Oncologists’ perceptions of
KRAS Testing. Proceedings of the HMO Research Network Meeting, Boston, MA
14. Spellman E, Sulayman N, Eggly S, Isaacs C, Peshkin BN, Schwartz MD, O’Neill SC. (March,
2011). Utility of Genomic Recurrence Risk Estimates in the Treatment of Patients with Early
Stage Breast Cancer: Physician Perspectives. Proceedings of the Annual Meeting of the Society
of Behavioral Medicine, Washington, DC.
15. Sulayman N, Spellman E, Graves KD, Peshkin BN, Schwartz MD, O’Neill SC. (March, 2011)
Impact of genomic breast cancer recurrence risk estimates on patient decision making,
psychosocial outcomes and quality of life. Proceedings of the Annual Meeting of the Society of
Behavioral Medicine, Washington, DC.
16. Kapp JM, O’Neill SC, Moser RP. (2010). Mammography use and risk perceptions of women
younger than the recommended age at which to begin routine screening. (March, 2011).
Proceedings of the Annual Meeting of the American Society of Preventive Oncology, Las Vegas,
NV.
17. Sanderson SC, Lipkus IM, Shepperd J, O’Neill SC, Docherty S, McBride CM. (November,
2010). Reactions of Smokers to an Information Pamphlet About Genetic Testing for a Common
Gene Variant Associated with Lung Cancer. Proceedings of the Annual Meeting of the American
Society of Human Genetics, Washington DC.
18. O’Neill SC, Lipkus IM, Sanderson SC, Shepperd J, Docherty S, McBride CM. (July, 2010).
Reliability and Predictive Validity of a Measure of Motivations for Genetic Testing for Common
Disease Risk. Proceedings of the Annual Meeting of the International Society of Behavioral
Medicine, Washington, DC.
19. O’Neill SC, McBride CM, Alford SH, Kaphingst KA. Do behavioral risk factors and genetic
causal beliefs diminish interest in seeking information about health habits? (March, 2010).
Proceedings of the Annual Meeting of the Society of Behavioral Medicine, Seattle, WA.
20. O’Neill SC, Graves KD, Kapp JM, Thompson CL, Worthington JL, Madlensky L. (March,
2010). Mentoring and Training Needs of American Society of Preventive Oncology Members and
Attendees of the 2009 Annual Meeting. Proceedings of the Annual Meeting of the American
Society of Preventive Oncology, Bethesda, MD.
21. Kapp JM, Graves KD, O’Neill SC, Thompson CL, Worthington JL, Madlensky L. (March,
2010). Characteristics of Junior Faculty Start-up Packages in the Field of Cancer Prevention.
Proceedings of the Annual Meeting of the American Society of Preventive Oncology, Bethesda,
MD.
22. Goddard KAB. et al. (2010). Comparative Effectiveness Research in Genomics & Personalized
Medicine for Colorectal Cancer. Proceedings of the Annual HMO Research Network Meeting.
23. Lipkus IM, Sanderson SC, Shepperd J, O’Neill SC, Docherty S, McBride CM. (October, 2009).
College smokers’ perceptions of lung cancer risk and desire to quit following genetic
susceptibility feedback: Preliminary findings of an ongoing randomized control trial. Proceedings
of the Genomic Applications in Practice and Prevention Network (GAPPNet), Ann Arbor, MI.
24. Goddard KAB, Whitlock EP, Kushi LH, Maciosek M, Feigelson HS. et al. (October, 2009).
Comparative Effectiveness Research in Genomics & Personalized Medicine for Colorectal
Cancer. Proceedings of the Genomic Applications in Practice and Prevention Network
(GAPPNet), Ann Arbor, MI.
25. DeFrank J, Bowling JM, Rimer BK, Gierisch J, Lipkus IM, Farrell D, O’Neill SC, Strigo TS,
Usinger D, Skinner CS. (March, 2009). Finding the minimal intervention needed for sustained
annual-interval mammography use: The PRISM Project. Proceedings of the Health Maintenance
Consortium, NIH, Bethesda, MD.
26. O’Neill SC, Peshkin BN, Luta G, Abraham A, Walker L, Tercyak KP. (March, 2009).
Adolescent medical providers’ willingness to offer BRCA1/2 testing to adolescents. Proceedings
of the Annual Meeting of the American Society of Preventive Oncology, Tampa, FL.
27. Sanderson SC, O’Neill SC, White DB, McBride CM. (March, 2008). Association and predictors
of congruence between interest in hypothetical and uptake of actual genetic testing. Proceedings
of the Annual Meeting of the Society of Behavioral Medicine, San Diego, CA.
28. O’Neill SC, Rini C, Goldsmith R, Valdimarsdottir H, Cohen LH, Schwartz MD. (March, 2008).
Distress among women receiving uninformative BRCA1/2 results: 12-month outcomes.
Proceedings of the Annual Meeting of the Society of Behavioral Medicine, San Diego, CA.
29. Lipkus IM, Bowling JM, Gierisch JM, O’Neill SC, Rimer BK. (March, 2008). When
ambivalence predicts mammography screening: It’s the amount of thought that counts.
Proceedings of the Annual Meeting of the Society of Behavioral Medicine, San Diego, CA.
30. O’Neill SC, Peshkin BN, Abraham A, Walker L, Luta G, Tercyak, KP. (March, 2008).
Adolescent medical providers’ interest in genetic testing: The impact of disease and patient
smoking behavior. Proceedings of the Annual Meeting of the Society of Behavioral Medicine,
San Diego, CA.
31. O’Neill SC, Bowling JM, Brewer NT, Lipkus IM, Strigo TS, Skinner CS, Rimer BK. (March,
2008). Women’s intentions to maintain adherence to mammography. Unpublished abstract.
Proceedings of the Annual Meeting of the American Society of Preventive Oncology, Bethesda,
MD.
32. O’Neill SC, White DB, Sanderson S, Lipkus IM, Bepler G, Bastian L, McBride CM. (December,
2007). Online genetic testing for lung cancer susceptibility: Predictors of uptake and decision
making in smokers related to lung cancer patients. Proceedings of the Frontiers in Cancer
Prevention Research Meeting, American Association for Cancer Research, Philadelphia, PA.
33. Kelleher S, Graves KD, DeMarco T, Hecker S, Peshkin BN, Isaacs C, Jandorf L, O’Neill, SC,
Valdimarsdottir H, Schwartz MD. (March, 2007). Deciding about decision aids: Predictors of use
of a CD-Rom decision aid. Proceedings of the Annual Meeting of the Society of Behavioral
Medicine, Washington DC.
34. O’Neill SC, Brewer NT, Lillie SE, Morrill EF, Dees EC, Carey LA, Rimer BK. (March, 2007).
Genomic screening for breast cancer recurrence risk and decision-making about chemotherapy.
Proceedings of the Annual Meeting of the Society of Behavioral Medicine, Washington DC.
35. Morrill EF, Brewer NT, O'Neill SC, Rimer BK, Lillie SE, Dees EC, Carey LA. (March, 2007).
The buffering effect of posttraumatic growth: Posttraumatic stress, depression and quality of life
among breast cancer survivors. Proceedings of the Annual Meeting of the Society of Behavioral
Medicine, Washington DC.
36. O’Neill SC, White DB, Lipkus IM, Bepler G, Bastian L, McBride CM. (March, 2007). Defensive
processing of GSTM1 test results. Unpublished abstract. Proceedings of the Annual Meeting of
the American Society of Preventive Oncology, Houston, TX.
37. O’Neill SC, Lipkus IM, Bowling JM, Rimer BK, Gierisch, JM. (March, 2006). Demographic and
attitudinal correlates of repeat mammography. Proceedings of the Annual Meeting of the Society
of Behavioral Medicine, San Francisco, CA.
38. Lillie SE, Brewer NT, O’Neill SC, Rimer BK, Dees EC, Carey LA. (March, 2006).
Communicating breast cancer recurrence risk: The role of health literacy. Proceedings of the
Annual Meeting of the Society of Behavioral Medicine, San Francisco, CA.
39. Brewer NT, O’Neill SC, Rimer BK, Dees EC, Carey LA. (March, 2006). Genomic testing for
breast cancer recurrence and decision-making about chemotherapy. Proceedings of the Annual
Meeting of the Society of Behavioral Medicine, San Francisco, CA.
40. O’Neill SC, Kaufman E, DeMarco T, Peshkin BN, McKenna K, Shelby R, Valdimarsdottir H,
Rispoli J, Schwartz MD. (February, 2006). Diet and exercise behaviors among women receiving
BRCA1/2 results. Proceedings of the Annual Meeting of the American Society of Preventive
Oncology, Bethesda, MD.
41. O’Neill SC, DeMarco T, Peshkin BN, Rogers S, Rispoli J, Brown K, Valdimarsdottir H,
Schwartz MD. (June, 2005). Intolerance for uncertainty and perceived risk as longitudinal
predictors of distress in women receiving uninformative genetic test results. Proceedings of the
International Meeting on the Psychosocial Aspects of Genetic Testing for Hereditary Cancer,
Philadelphia, PA.
42. Gierisch JM & O’Neill SC. (March, 2005). Recruitment of a Member Advisory Panel to enhance
tailored communications. Proceedings of the Annual Meeting of the American Society of
Preventive Oncology, San Francisco, CA.
43. O’Neill SC, DeMarco T, Peshkin BN, Rogers S, Rispoli J, Brown K, Valdimarsdottir H,
Schwartz MD. (March 2005). Perceived risk and intolerance for uncertainty as predictors of
distress in women receiving uninformative genetic test results. Proceedings of the Annual
Meeting of the Society of Behavioral Medicine, Boston, MA
44. O’Neill SC, DeMarco T, Peshkin BN, Rogers S, Rispoli J, Brown K, Valdimarsdottir H,
Schwartz MD. (March, 2004). Personality and genetic test results as predictors of distress in
women receiving genetic test results. Proceedings of the Annual Meeting of the Society of
Behavioral Medicine, Baltimore, MD. (Citation award)
45. Carter CL, Zapka JG, O’Neill SC, DesHarnais S, Hennessy W, Kurent J, Carter, R. (April, 2004).
Clinical perspectives in end-of-life care: Factors of race, specialty and location. Proceedings of
the Annual Meeting of the American Psychosocial Oncology Society, Orlando, FL.
46. O’Neill SC, Cohen LH, Tolpin LH, Gunthert KC (October, 2002). Negative affective reactivity
to daily interpersonal stress as a predictor of depression. Proceedings of the Annual Meeting of
the Association for Advancement of Behavior Therapy, Philadelphia, PA.
47. Tolpin LH, Gunthert KC, Cohen LH, O’Neill SC (October, 2002). Borderline personality and
instability of state depression and self-esteem. Proceedings of the Annual Meeting of the
Association for Advancement of Behavior Therapy, Philadelphia, PA
48. Tidey JW, O’Neill SC, Higgins ST. (August, 1999). d-amphetamine increases choice of cigarette
smoking versus monetary reinforcement. Proceedings of the Annual Meeting of the American
Psychological Association, Boston, MA.
49. Tidey JW, O’Neill SC, Higgins ST. (June, 1998). Effects of contingent monetary reinforcement
and transdermal nicotine on cigarette smoking by schizophrenics. Proceedings of the Annual
Meeting of the College on Problems of Drug Dependence, Acapulco, Mexico.
50. Tidey JW, O’Neill SC, Higgins ST. (August, 1998). Assessing the sensitivity of drug use by
schizophrenics to systematic environmental manipulations. Proceedings of Addictions ’98,
Newcastle-on-Tyne, England
51. O’Neill, SC & Hannum, JW (August 1998). An examination of coping, neuroticism and
appraisal. Proceedings of the Annual Meeting of the American Psychological Association, San
Francisco, CA.
B. Research Funding:
i. Active Grants:
Agency: National Cancer Institute
Identifying Number: R01 CA190221
Title of Project: Applying Breast Density to Risk Counseling
Dates of Project Period: 7/1/15-6/30/19
Corresponding PI: Suzanne C. O’Neill
Total Direct Costs over all years of award: $ 1,618,451
Total Indirect Costs over all years of award: $ 353,230
Total Direct plus Indirect Costs over all years of award: $ $1,971,681
Role: Primary Investigator
Percent Effort: Effort: 30%
Agency: American Cancer Society Mentored Research Scholar Grant
Identifying Number: CPPB-10-110-01
Title of Project: Making Informed Breast Cancer Decisions Using Genomic Testing
Title of Project Period: 7/1/10 – 6/30/16 (nce)
Corresponding PI: Suzanne C. O’Neill
Total Direct Costs over all years of award: $ 675,000
Total Indirect Costs over all years of award: $ 54,000
Total Direct plus Indirect Costs over all years of award: $729,000
Role: Primary Investigator
Percent Effort: 47.5%
Agency: National Cancer Institute
Identifying Number: R03 CA178763
Title of Project: Young Women from BRCA1/2 Families: a Family History and a Future
Title of Project Period: 9/15/14-9/14/16
Corresponding PI: Suzanne C. O’Neill
Total Direct Costs over all years of award: $ 100,000
Total Indirect Costs over all years of award: $ 55,500
Total Direct plus Indirect Costs over all years of award: $ 155,500
Role: Primary Investigator
Percent Effort: 15%
Agency: Nine Hyde Advancement Developmental Funds Award-Senior
Title of Project: The Effects of Gene Expression Profiling on Breast Cancer Survivors’ Care
Dates of Project: 8/1/15-7/31/16
Corresponding PI: Suzanne C. O’Neill and Arnold Potosky
Total Direct Costs over all years of award: $23,349
Total Indirect Costs over all years of award: $ 0
Total Direct plus Indirect Costs over all years of award: $23,349
Role: Primary Investigator (MPI, Arnold Potosky)
Percent Effort: In-kind
Agency: CDC/DCPC
Identifying Number: U58DP005408
Title of Project: LINK Program: Enhancing and Sustaining Structured Breast Cancer Support Services for
Young Jewish Women
Title of Project Period: 9/30/14-9/29/17
Corresponding PI: Kenneth Tercyak and Sharsheret
Total Direct Costs over all years of award: $ 129,183
Total Indirect Costs over all years of award: $ 0
Total Direct plus Indirect Costs over all years of award: $ 129,183
Role: Co-investigator
Percent Effort: 2.5%
Agency: National Cancer Institute
Identifying Number: 1U01CA183081
Title of Project: Optimizing Personalized Care Using Economic Studies of Genomic Testing
Dates of Project Period: 9/1/13-8/31/18
Corresponding PI: Jeanne Mandelblatt
Total Direct Costs over all years of award: $ 779,660
Total Indirect Costs over all years of award: $ 201,106
Total Direct plus Indirect Costs over all years of award: $ 980,766
Role: Co-investigator
Percent Effort: 5%
ii. Submitted (Not yet funded):
Agency: National Cancer Institute
Identifying Number: 1U01CA183081
Title of Project: Administrative Supplement, Optimizing Personalized Care Using Economic Studies of
Genomic Testing
Dates of Project Period: 9/1/15-8/31/17
Corresponding PI: Suzanne C. O’Neill
Total Direct Costs over all years of award: $190,858
Total Indirect Costs over all years of award: $74,138
Total Direct plus Indirect Costs over all years of award: $264,996
Role: Primary Investigator
Percent Effort: 15%
Agency: National Cancer Institute
Identifying Number: R21 CA201827
Title of Project: A Question Prompt List to Promote Communication in Genomic Medicine
Dates of Project Period: 12/1/15-11/30/17
Corresponding PI: Suzanne C. O’Neill
Total Direct Costs over all years of award: $275,000
Total Indirect Costs over all years of award: $185,745
Total Direct plus Indirect Costs over all years of award: $460,745
Role: Primary Investigator
Percent Effort: 20%
A0=12th percentile
Agency: National Cancer Institute
Identifying Number: R21 CA194965
Title of Project: Evolving Models for Genetic Counseling in Panels: Clinical Decisions and Outcomes
Dates of Project Period: 12/1/15-11/30/17
Corresponding PI: Marc D. Schwartz and Beth Peshkin
Total Direct Costs over all years of award: $275,000
Total Indirect Costs over all years of award: $152,625
Total Direct plus Indirect Costs over all years of award: $427,625
Role: Co-investigator
Percent Effort: 7.5%
A1=2nd percentile
Agency: National Cancer Institute
Identifying Number: R21 CA197320
Title of Project: Psychosocial Intervention for Partners of Patients with Genetic Breast Cancer Risk
Dates of Project Period: 4/1/16-3/31/18
Corresponding PI: Kenneth Tercyak and Frances Marcus Lewis
Total Direct Costs over all years of award: $275,000
Total Indirect Costs over all years of award: $176,921
Total Direct plus Indirect Costs over all years of award: $451,921
Role: Co-investigator
Percent Effort: 7.5%
iii. Previous
Agency: Prevent Cancer Foundation
Title of Project: Making Informed Breast Cancer Primary Prevention Decisions
Dates of Project: 7/15/11-1/14/14
Corresponding PI: Suzanne C. O’Neill
Total Direct Costs over all years of award: $80,000
Total Indirect Costs over all years of award: $ 0
Total Direct plus Indirect Costs over all years of award: $ $80,000
Role: Primary Investigator
Percent Effort: 10%
Agency: Nine Hyde Advancement Developmental Funds Award-Junior
Title of Project: Young Women from BRCA1/2 Families: A Pilot Study
Dates of Project: 6/1/13-5/31/14
Corresponding PI: Suzanne C. O’Neill
Total Direct Costs over all years of award: $25,000
Total Indirect Costs over all years of award: $ 0
Total Direct plus Indirect Costs over all years of award: $ $25,000
Role: Primary Investigator
Percent Effort: In-kind
Agency: American Cancer Society Institutional Research Grant
Identifying Number: ACS IRG 97-152-16
Title of Project: Breast Cancer Patients’ Experiences with Oncotype Dx Testing
Dates of Project: 10/1/08-9/1/09
Corresponding PI: Suzanne C. O’Neill
Total Direct Costs over all years of award: $20,000
Total Indirect Costs over all years of award: $ 0
Total Direct plus Indirect Costs over all years of award: $ $20,000
Role: Primary Investigator
Percent Effort: In-kind
Agency: National Institutes of Health/National Cancer Institute
Identifying Number: R01 CA135179
Title of Project: Internet-Based Decision Support for BRCA1/BRCA2 Carriers
Dates of Project: 7/1/09-5/31/16
Corresponding PI: Marc D. Schwartz
Total Direct Costs over all years of award: $ 1,572,419
Total Indirect Costs over all years of award: $ 569,824
Total Direct plus Indirect Costs over all years of award: $ $2,142,243
Role: Co-investigator
Percent Effort: 5%
Agency: National Institutes of Health/National Cancer Institute
Identifying Number: R01 CA16067101A1
Title of Project: Impact of Genomic and Personalized Medicine in Women Under age 65 with Breast
Cancer
Dates of Project: 9/1/12 – 8/31/15
Corresponding PI: Arnold Potosky
Total Direct Costs over all years of award: $ 685,034
Total Indirect Costs over all years of award: $ 198,231
Total Direct plus Indirect Costs over all years of award: $ 883,265
Role: Co-investigator
Percent Effort: 5%
Agency: National Institutes of Health/National Cancer Institute
Identifying Number: R01 CA137625
Title of Project: Adolescents’ Long-Term Adaptation to Familial Cancer Risks
Dates of Project: 12/17/09 – 11/30/15
Corresponding PI: Kenneth Tercyak
Total Direct Costs over all years of award: $2,242,769
Total Indirect Costs over all years of award: $668,416
Total Direct plus Indirect Costs over all years of award: $2,911,185
Role: Co-investigator
Percent Effort: 5%
Agency: National Institutes of Health/National Cancer Institute
Identifying Number: R03 CA165147
Title of Project: HPV Knowledge, Awareness and Vaccine Acceptability among Inner City Black Males
Dates of Project: 9/25/12-08/31/15
Corresponding PI: Sherrie Wallington
Total Direct Costs over all years of award: $ 97,000
Total Indirect Costs over all years of award: $ 53,350
Total Direct plus Indirect Costs over all years of award: $ 150,350
Role: Co-investigator
Percent Effort: 2%
Agency: National Institutes of Health/National Cancer Institute
Identifying Number: UC2 CA148471-01
Title of Project: Comparative Effectiveness in Genomic and Personalized Medicine for Colon Cancer
Dates of Project: 9/29/09 –8/31/11
Corresponding PI: Katrina Goddard, Larry Kushi and Evelyn Whitlock
Total Direct Costs over all years of award: $3,507,386
Total Indirect Costs over all years of award: $ 484,422
Total Direct plus Indirect Costs over all years of award:$ 3,991,808
Role: Co-investigator
Percent Effort: 5%
Agency: National Institutes of Health/National Human Genome Research Institute
Identifying Number: R01 HG005055
Title of Project: Internet Intervention for BRCA1/2 Uninformatives
Dates of Project: 9/23/08-7/31/11
Corresponding PI: Dr. Marc Schwartz
Total Direct Costs over all years of award: $1,335,196
Total Indirect Costs over all years of award: $515,990
Total Direct plus Indirect Costs over all years of award: $1,851,186
Role: Co-investigator
Percent Effort: 5%
C. Invited Lectures:
Visiting Professorship, Department of Behavioral Science and Health Education, Rollins School of Public
Health, Emory University, Atlanta, GA, March, 2015
Grand Rounds, “Breast Cancer Prevention and Control” Virginia Hospital Center, Arlington, VA,
November, 2014
Invited Speaker, American Cancer Society Symposium, Lombardi Comprehensive Cancer Center,
Washington, DC, September, 2014
Invited Symposium Participant, “Genomic Advances and Patient Decision Making” Annual Meeting of
the Society of Behavioral Medicine, Philadelphia, PA, April, 2014
Invited Presenter, Translating Genomics Through a Social and Behavioral Lens: 10th Anniversary of the
Social and Behavioral Research Branch, NHGRI, NIH, Bethesda, MD, January, 2014
Invited Panelist, Applying to Graduate School in Psychology, Department of Psychology, Georgetown
University, October, 2013
Visiting Professorship, Karmanos Cancer Center, Detroit, MI, April, 2013
Session Chair, Featured Symposium, Patient-Centered Outcomes Research Institute and Partners:
Improving Patient Outcomes through Behavioral Medicine Research” Annual Meeting of the Society of
Behavioral Medicine, San Francisco, CA, April, 2013
Scientific Session, “Women’s Awareness of Mammographic Breast Density,” Annual Meeting of the
Society of Behavioral Medicine, San Francisco, CA, April, 2013
Scientific Session, “Mammographic Breast Density as a Breast Cancer Risk Factor: Implications for
Intervention,” Annual Meeting of the Society of Behavioral Medicine, San Francisco, CA, March, 2013
Presentation and Roundtable Discussion, “Young Women’s Workshop,” Annual Meeting of FORCE
(Facing our Risk of Cancer Empowered), Orlando, FL, October, 2012
Closing Plenary, “Quality of Life and Cancer,” ACS Cancer Action Network National Meeting,
Washington, DC, September, 2012
Dinner Speaker, “Communicating Breast Density as a Risk Factor,” Annual Holden Cup fundraiser for
the Prevent Cancer Foundation, Alexandria, VA, September, 2012
Session Chair, Symposium, “Opportunities for translational research using the DECISIONS Study: A
conversation between SBM’s Decision Making SIG and the Society for Medical Decision Making,”
Annual Meeting of the Society of Behavioral Medicine, Washington, DC, March, 2011
Session Co-Chair, Symposium, “When decisions depart from rationality: Evidence-based strategies for
understanding “real” patient choices,” Annual Meeting of the Society for Medical Decision Making,
Chicago, IL, October, 2011
Scientific Session, “Breast Cancer Prevention: Predictors and Outcomes of Patient Decision Making,”
Frontiers in Cancer Prevention Research Meeting, American Association for Cancer Research,
Philadelphia, PA, November, 2010
Media Event, “Privacy and Testing—what do people want?” Human Genome: A decade of discovery,
creating a healthy future. NGHRI Event for Health and Science Media in honor of the 10th Anniversary
of the sequencing of the human genome, Washington, DC, June, 2010
Scientific Session, “Genomics as a Biomarker,” 34th Annual Meeting of the American Society of
Preventive Oncology, Bethesda, MD, March, 2010
Invited Speaker, “Careers in Health Psychology and Academic Medicine,” University of Delaware,
Department of Psychology, Newark, DE, March, 2010
Scientific Session, “The impact of family history and behavioral risk on disease attributions,” Annual
Meeting of the American Public Health Association, San Diego, CA, September, 2008
Scientific Session, “Distress among women receiving uninformative BRCA1/2 results: 12-month
outcomes,” Annual Meeting of the Society of Behavioral Medicine, San Diego, CA, March, 2008
Scientific Session, “Adolescent medical providers’ interest in genetic testing: The impact of disease and
patient smoking behavior,” Annual Meeting of the Society of Behavioral Medicine, San Diego, CA,
March, 2008
Intramural Scientific Retreat, “Online genetic testing for lung cancer susceptibility: Predictors of uptake
and decision making in smokers related to lung cancer patients.” National Human Genome Research
Institute, November, 2007
Scientific Session, “Genomic screening for breast cancer recurrence risk and decision-making about
chemotherapy,” Annual Meeting of the Society of Behavioral Medicine, Washington, DC, March, 2007
Scientific Session, “Intolerance for uncertainty and perceived risk as longitudinal predictors of distress in
women receiving uninformative genetic test results,” 9th International Meeting on the Psychosocial
Aspects of Genetic Testing for Hereditary Cancer, Philadelphia, PA, June, 2005
Medical Resident Education, “Motivational Interviewing,” Internal Medicine Department, Ralph H.
Johnson VA Medical Center, Charleston, SC, April, 2004
Medical Resident Education, “Discussing Difficult News with Patients and Families,” Psychiatry
Department, Medical University of South Carolina, Charleston, SC, March, 2004
D. Editorships, Editorial Boards, and Reviewing Activities
Annals of Behavioral Medicine (Society of Behavioral Medicine Journal), Editorial Board, 2015-present
Health Psychology (American Psychological Association Journal), Editorial Board, 2015-present
Journal of Cancer Epidemiology, Invited Editor of Special Issue, Cancer: The Front Line of Genomic
Translation, 2012
American Cancer Society, Member, Cancer Control and Prevention Research: Psychosocial and
Behavioral Research Committee (CPPB), 2012-present
Canadian Cancer Society Research Institute (formerly National Cancer Institute of Canada), Ad Hoc
Scientific Grant Reviewer, Quality of Life Panel, 2012-present
American Cancer Society, Ad Hoc Scientific Reviewer, Cancer Control and Prevention Research:
Psychosocial and Behavioral Research Committee (CPPB), 2012
National Institutes of Health, National Cancer Institute, Ad Hoc Scientific Reviewer, ARRA Grant
mechanism, 2010
American Journal of Managed Care, Manuscript Reviewer
American Journal of Preventive Medicine, Manuscript Reviewer
BMC Family Practice, Manuscript Reviewer
Cancer Epidemiology Biomarkers and Prevention, Manuscript Reviewer
Cancer, Manuscript Reviewer
Cancer Detection and Prevention, Manuscript Reviewer
European Journal of Human Genetics, Manuscript Reviewer
Genetics in Medicine, Manuscript Reviewer
Health Education Research, Manuscript Reviewer
Health Education and Behavior, Manuscript Reviewer
Journal of Consulting and Clinical Psychology, Manuscript Reviewer
Journal of Genetic Counseling, Manuscript Reviewer
Journal of Pediatric Psychology, Manuscript Reviewer
Journal of Personality, Manuscript Reviewer
Journal of Psychosomatic Research, Manuscript Reviewer
Medical Decision Making, Manuscript Reviewer
Preventive Medicine, Manuscript Reviewer
Psycho-Oncology, Manuscript Reviewer
Quality of Life Research, Manuscript Reviewer
Review of Hereditary Cancer in Clinical Practice, Manuscript Reviewer
Women and Health, Manuscript Reviewer
3. TEACHING, MENTORING, AND ADVISING
A. Teaching Activities
i. Medical School Courses
Name: Physician Patient Communication
Role: Small Group Leader
Number of Direct Contact Hours: 8
Year Taught: 2010
Number of Students: 8
Overall Evaluation Score: 4.5/5
Name: Physician Patient Communication
Role: Small Group Leader
Number of Direct Contact Hours: 8
Year Taught: 2011
Number of Students: 8
Overall Evaluation Score: 4.4/5
Name: Patient and Physician Communication
Role: Small Group Leader
Number of Direct Contact Hours: 8
Year Taught: 2012
Number of Students: 8
Overall Evaluation Score: 4.4/5
Name: Patient and Physician Communication
Role: Small Group Leader
Number of Direct Contact Hours: 8
Year Taught: 2013
Number of Students: 8
Overall Evaluation Score: 4.5/5
Name: Patient and Physician Communication
Role: Small Group Leader
Number of Direct Contact Hours: 8
Year Taught: 2014
Number of Students: 8
Overall Evaluation Score: 4.6/5
Name: Patient and Physician Communication
Role: Small Group Leader
Number of Direct Contact Hours: 8
Year Taught: 2015
Number of Students: 8
Overall Evaluation Score: 4.4/5
Name: Physician Patient Communication
Role: Guest Substitute Preceptor
Number of Direct Contact Hours: 6
Year Taught: Fall 2013, 2014
Number of Students: 8
Overall Evaluation Score: Not administered (Substitute)
ii. Medical School Clerkships
N/A
iii. Graduate Biomedical Education Courses
Name and Course Number: Principles and Practice of Behavioral Science in Cancer Control (TBIO 532)
Role: Lecturer
Lecture Title: “Impact of Hereditary Cancer on the Patient and the Family”
Number of Direct Contact Hours: 2 total
Years Taught: 2009
Number of Students: < 15 students per class
Overall Evaluation Score: 4.5/5
Name and Course Number: Principles and Practice of Behavioral Science in Cancer Control (TBIO 532)
Role: Lecturer
Lecture Title: “Foundations of Behavior Theory: Assessment and Treatment”
Number of Direct Contact Hours: 2 total
Years Taught: 2010
Number of Students: < 15 students per class
Overall Evaluation Score: 5/5
Name and Course Number: Principles and Practice of Behavioral Science in Cancer Control (TBIO 532)
Role: Lecturer
Lecture Title: “Foundations of Behavior Theory: Assessment and Treatment”
Number of Direct Contact Hours: 2 total
Years Taught: 2011
Number of Students: < 15 students per class
Overall Evaluation Score: 4.5/5
Name and Course Number: Principles and Practice of Behavioral Science in Cancer Control (TBIO 532)
Role: Lecturer
Lecture Title: “Foundations of Behavior Theory: Assessment and Treatment”
Number of Direct Contact Hours: 2 total
Years Taught: 2012
Number of Students: < 15 students per class
Overall Evaluation Score: 5/5
Name and Course Number: Principles and Practice of Behavioral Science in Cancer Control (TBIO 532)
Role: Lecturer
Lecture Title: “Foundations of Behavior Theory: Assessment and Treatment”
Number of Direct Contact Hours: 2 total
Years Taught: 2013
Number of Students: < 15 students per class
Overall Evaluation Score: 4.73/5
Name and Course Number: Principles and Practice of Behavioral Science in Cancer Control (TBIO 532)
Role: Lecturer
Lecture Title: “Risk-stratified cancer screening: Beyond the basics”
Number of Direct Contact Hours: 2 total
Years Taught: 2014
Number of Students: < 15 students per class
Overall Evaluation Score: 4.95/5
iv. Course Directorships
Name and Course Number: Introduction to Epidemiology, Prevention and Cancer Control (TBIO 520)
Role: Course Director
Number of Direct Contact Hours: 20
Year Taught: 2013
Number of Students: 14
Overall Evaluation Score: 4.6/5
Name and Course Number: Introduction to Epidemiology, Prevention and Cancer Control (TBIO 520)
Role: Course Director
Number of Direct Contact Hours: 20
Year Taught: 2014
Number of Students: 15
Overall Evaluation Score: 4.7/5
Name and Course Number: Introduction to Epidemiology, Prevention and Cancer Control (TBIO 520)
Role: Course Director
Number of Direct Contact Hours: 20
Year Taught: 2015
Number of Students: 13
Overall Evaluation Score: 4.7/5
B. Mentoring:
i. Mentor:
Name of Mentee: Elizabeth Spellman (Boston College School of Social Work; former Research
Assistant)
Dates of Mentorship: 2010-2013
Publications:

King L, *O’Neill SC, Spellman E, Peshkin BN, Valdimarsdottir H, Willey S, Leventhal KG,
DeMarco T D, Nusbaum R, Schwartz MD. (2012). Intentions for Bilateral Mastectomy Among
Newly Diagnosed Breast Cancer Patients. Annals of Surgical Oncology, 107, 772-776.
*Corresponding author

Spellman E, Sulayman N, Eggly S, Isaacs C, Peshkin B N, Schwartz MD, O’Neill SC. (2013).
Utility of Genomic Recurrence Risk Estimates in the Treatment of Patients with Early Stage
Breast Cancer: Physician Perspectives. Psycho-Oncology, 22, 2110-2116.

Sulayman N, Spellman E, Graves KD, Peshkin BN, Isaacs C, Schwartz MD, O’Neill SC. (2012).
Psychosocial and quality of life outcomes in women receiving the 21-gene Recurrence Score
assay: the impact of decision style in women with intermediate RS. Journal of Cancer
Epidemiology, Special Issue on Translational Genomics, 2012, 728290.
Presentations:

Spellman E, Sulayman N, DeMarco TA, Sharff ME, Tercyak KP, Friedman S, O’Neill SC.
(March, 2012). Listening to the Internet: Young previvors needs for decision and psychosocial
support. Proceedings Annual Meeting of the American Society of Preventive Oncology,
Washington, DC.

Spellman E, Sulayman N, Eggly S, Isaacs C, Peshkin BN, Schwartz MD, O’Neill SC. (March,
2011). Utility of Genomic Recurrence Risk Estimates in the Treatment of Patients with Early
Stage Breast Cancer: Physician Perspectives. Proceedings Annual Meeting of the Society of
Behavioral Medicine, Washington, DC.

Sulayman N, Spellman E, Graves KD, Peshkin BN, Schwartz MD, O’Neill SC. (March, 2011)
Impact of genomic breast cancer recurrence risk estimates on patient decision making,
psychosocial outcomes and quality of life. Proceedings Annual Meeting of the Society of
Behavioral Medicine, Washington, DC.

O’Neill SC, Sulayman N, Spellman E, Leventhal KG, Scarles M. (2013, April). Women’s
Awareness of Mammographic Breast Density. Proceedings Society of Behavioral Medicine, San
Francisco, CA.

O’Neill SC, Sulayman N, Spellman E, Leventhal KG, Scarles M. (2013, April). Mammographic
Breast Density as a Breast Cancer Risk Factor: implications for Intervention. Proceedings
Society of Behavioral Medicine, San Francisco, CA.

O’Neill SC, Sulayman N, Spellman E, Graves KD, Peshkin BN, Schwartz MD. (June, 2012).
Associations between genomic breast cancer recurrence risk estimates and treatment and
screening utilization. Proceedings AcademyHealth, Orlando, FL.
Name of Mentee: Nadiyah Sulayman (Clinical Research Coordinator, University of Washington, former
Research Assistant)
Dates of Mentorship: 2008-2013
Publications:

Spellman E, Sulayman N, Eggly S, Isaacs C, Peshkin B N, Schwartz MD, O’Neill SC. (2013).
Utility of Genomic Recurrence Risk Estimates in the Treatment of Patients with Early Stage
Breast Cancer: Physician Perspectives. Psycho-Oncology, 22, 2110-2116.

Sulayman N, Spellman E, Graves KD, Peshkin BN, Isaacs C, Schwartz MD, O’Neill SC. (2012).
Psychosocial and quality of life outcomes in women receiving the 21-gene Recurrence Score
assay: the impact of decision style in women with intermediate RS. Journal of Cancer
Epidemiology, Special Issue on Translational Genomics, 2012, 728290.
Presentations:

Spellman E, Sulayman N, DeMarco TA, Sharff ME, Tercyak KP, Friedman S, O’Neill SC.
(March, 2012). Listening to the Internet: Young previvors needs for decision and psychosocial
support. Proceedings Annual Meeting of the American Society of Preventive Oncology,
Washington, DC.

Spellman E, Sulayman N, Eggly S, Isaacs C, Peshkin BN, Schwartz MD, O’Neill SC. (March,
2011). Utility of Genomic Recurrence Risk Estimates in the Treatment of Patients with Early
Stage Breast Cancer: Physician Perspectives. Proceedings Annual Meeting of the Society of
Behavioral Medicine, Washington, DC.

Sulayman N, Spellman E, Graves KD, Peshkin BN, Schwartz MD, O’Neill SC. (March, 2011)
Impact of genomic breast cancer recurrence risk estimates on patient decision making,
psychosocial outcomes and quality of life. Proceedings Annual Meeting of the Society of
Behavioral Medicine, Washington, DC.

O’Neill SC, Sulayman N, Spellman E, Leventhal KG, Scarles M. (2013, April). Women’s
Awareness of Mammographic Breast Density. Proceedings Society of Behavioral Medicine, San
Francisco, CA.

O’Neill SC, Sulayman N, Spellman E, Leventhal KG, Scarles M. (2013, April). Mammographic
Breast Density as a Breast Cancer Risk Factor: implications for Intervention. Proceedings
Society of Behavioral Medicine, San Francisco, CA.

O’Neill SC, Sulayman N, Spellman E, Graves KD, Peshkin BN, Schwartz MD. (June, 2012).
Associations between genomic breast cancer recurrence risk estimates and treatment and
screening utilization. Proceedings AcademyHealth, Orlando, FL.
Name of Mentee: Kara-Grace Leventhal (Georgetown University School of Medicine, class of 2019;
former Project Director)
Dates of Mentorship: 2013-2014
Publication:

O’Neill SC, Leventhal KG, Scarles M, Evans C, Makariou E, Pien E, Willey S. (2014).
Mammographic breast density as a risk factor for breast cancer: Awareness in a RecentlyScreened Clinical Sample. Women’s Health Issues, 24, e321-326.
Presentations:

O’Neill SC, Sulayman N, Spellman E, Leventhal KG, Scarles M. (2013, April). Women’s
Awareness of Mammographic Breast Density. Proceedings Society of Behavioral Medicine, San
Francisco, CA.

O’Neill SC, Sulayman N, Spellman E, Leventhal KG, Scarles M. (2013, April). Mammographic
Breast Density as a Breast Cancer Risk Factor: implications for Intervention. Proceedings
Society of Behavioral Medicine, San Francisco, CA.
Name of Mentee: Chalanda Evans (current Research Assistant)
Dates of Mentorship: 2013-present
Presentations:

Evans C, Eggly S, Isaacs C, Schwartz MD, Vadaparampil S, O’Neill SC. (2015, August). Risk of
Recurrence and Quality of Provider Communication Predict Treatment-Related Decisional
Conflict among Women with Breast Cancer. Proceedings International Psychosocial Oncology
Society, Washington, DC.

Evans C, Nusbaum R, Isaacs C, Tercyak KP, O’Neill SC. (2015, April). Assessing patient
education and counseling needs of young women at high risk for breast cancer. Proceedings
Society of Behavioral Medicine, San Antonio, TX.

Evans C, Willey S, Makariou E, Pien E, Leventhal KG, Scarles M, O’Neill SC. (2014, March).
Integrating breast density into risk counseling: pilot intervention outcomes. Proceedings
American Society of Preventive Oncology, Arlington, VA.
Name of Mentee: Ariana Santopietro, medical student, GUSOM, class of 2018.
Dates of Mentorship: 2015-present
Name of Mentee: Stephanie Galloway, genetic counseling Master’s student, University of South Carolina
Genetic Counseling Program, class of 2016. Thesis Committee Member
Dates of Mentorship: 2015-present
ii. Co-Mentor:
Name of Mentee: Leslie King (University of Washington School of Medicine; former Research Assistant
at Lombardi Comprehensive Cancer Center, Georgetown University Medical Center), co-mentored with
Marc D. Schwartz
Dates of Mentorship: 2010-2012
Publication:

King L, *O’Neill SC, Spellman E, Peshkin BN, Valdimarsdottir H, Willey S, Leventhal KG,
DeMarco T D, Nusbaum R, Schwartz MD. (2012). Intentions for Bilateral Mastectomy Among
Newly Diagnosed Breast Cancer Patients. Annals of Surgical Oncology, 107, 772-776.
*Corresponding author
Name of Mentee: Kantoniony Rabemananjara, Undergraduate Student, Georgetown University, comentored with Kenneth P. Tercyak
Dates of Mentorship: 2014-2015
Outcome: BA, May 2015
4. SERVICE
A. University Service:
i. Department
Population Science Review Chair, Protocol Review and Monitoring System/Clinical Research
Committee, Lombardi Comprehensive Cancer Center, GUMC, 2013-present
Cancer Prevention and Control Disease Group Review Committee, Lombardi Comprehensive Cancer
Center, GUMC, 2013-present
Behavioral Scientist Representative, Clinical Research Committee, Lombardi Comprehensive Cancer
Center, GUMC, 2011-present
Triage Committee, Non-Therapeutic Shared Resource, Lombardi Comprehensive Cancer Center, GUMC,
2012-present
ii. School
Board Member-at-Large, Georgetown Women in Medicine, GUMC, 2009-2011, 2013-present
Applicant Interviewer, GUMC Admissions Committee, 2014-present
Member, Research Committee, GUMC, 2011-present
iii. University
Equal Opportunity Examining Board, Office of Institutional Diversity, Equity and Affirmative Action,
Georgetown University, 2014-present
B. MedStar or Hospital Service
N/A
C. Professional Service:
2001-present, Society of Behavioral Medicine
 2014-present, Track Co-Chair, Psychological and Person Factors in Health and Behavior Change
 2010-2014, Member, Scientific and Professional Liaison Committee (Liaison with the Society for
Medical Decision Making
 2012-2013, Chair, Health Decision Making Special Interest Group
 2011-2012, Co-Chair, Health Decision Making Special Interest Group
 2007-present, Scientific Abstract Reviewer
2004-present, American Society of Preventive Oncology
 2009-2012, Executive Committee Member
 2011, Chair, Nominating Committee
 2009, Conference Planning Committee
 2008, Chair, Career Development Seminar
2010-present, Society for Medical Decision Making

2012-present, Scientific Abstract Reviewer
2013-present, National Cancer Institute

Cancer Trends Progress Report, External Advisory Committee
2014, Dissertation reader, Louise Heiniger, student of Dr. Phyllis Butow, University of Sydney, Australia
2015, CDC EGAPP Working Group, Tumor Gene Expression Profiling for Breast Cancer
Recommendation, External Reviewer
5. HONORS AND AWARDS
Dean’s List, University of Notre Dame, 1993-1995
Kappa Delta Pi Honor Society, University of Illinois, 1997
Meritorious Poster Citation (1st Author; Dissertation), Society of Behavioral Medicine, 2004
Cancer Control Education Program Postdoctoral Fellow, Competitive Postdoctoral Fellowship at the R25funded UNC Lineberger Comprehensive Cancer Center, 2004-2006
Susan G. Komen Foundation Travel Award, 2005
NIH Women’s Health Postdoctoral Fellowship, Competitive NIH Intramural Postdoctoral Fellowship cosponsored by the NIH ORWH and the Battelle Corporation, 2006-2008
John Eisenberg Career Development Award, Georgetown Women in Medicine, Georgetown University
Medical Center, Washington, DC, 2012
Loan Repayment Program (Competitive), National Institutes of Health, Bethesda, MD, 2009-2013
6. PROFESSIONAL SOCIETY MEMBERSHIP
2001-present, Society of Behavioral Medicine; SIG Chair, Track Co-Chair
2004-present, American Society of Preventive Oncology, Executive Committee Member
2010-present, Society for Medical Decision Making
I certify that this curriculum vita is a current and accurate statement of my professional record.
Signature:_____
__________
Date: ____6/16/15_____________________
Download
Related flashcards

Oncology

38 cards

Oncology

48 cards

Cancer organizations

24 cards

Tumor markers

15 cards

Create Flashcards